Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman who has recently been diagnosed with a weakened heart (either caused by blocked arteries or another reason), and your heart's pumping ability is at or below 35% at the time you are given a wearable heart device (WCD).
- You have been prescribed the wearable heart device with a plan to wear it for about 90 days (anywhere from 76 to 104 days).
- You have been wearing the wearable heart device for no more than 14 days since you agreed to join the study.
- You have not been hospitalised for heart failure in the 30 days before joining the study.
- You are 18 years of age or older at the time you agree to take part.
- To continue into the second phase of the trial, you must have been actively wearing the device for at least 15 hours per day (105 hours per week) during the first two weeks.
Who may not be able to join:
- You cannot tolerate or have a medical reason to avoid a type of heart medication called beta-blockers.
- You have a permanent irregular heart rhythm known as atrial fibrillation.
- You have a pacemaker.
- You currently have, or have previously had, an implanted heart device designed to correct dangerous heart rhythms (an ICD).
- You are pregnant (based on self-report).
- You have a heart condition that you were born with or that runs in your family.
- You are already taking part in another clinical trial that involves a treatment or device.
- You are not expected to live longer than 3 months.
- You stopped wearing the wearable heart device within the first two weeks (this would prevent you from continuing into the second phase).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Valentina Kutyifa, MD PHD, University of Rochester
Phone: 412-968-3333
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Heart Rate Control
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.